Immunocytochemical detection of Rhodococcus equi in tracheal washes of foals.

The research is aimed at developing an immunocytochemical procedure for the early detection of Rhodococcus equi, a bacteria causing illness in foals. The study found no significant difference in the detection capability between enzyme-linked immunosorbent assay (ELISA) and the new immunocytochemistry (ICC) method.

Methodology

• The researchers devised an immunocytochemical procedure to identify Rhodococcus equi in tracheal aspirates, or wash samples, from live foals.
• The sample group consisted of thoroughbred foals aged between 1 and 5 months situated in studs around Bursa and Istanbul, Turkey.
• Among these foals, some were suspected of an R. equi infection based on clinical examination (n=56) whereas others were without symptoms and served as control animals (n=54).
• Additionally, serum samples were taken from every foal to test for R. equi-specific antibodies using enzyme linked immunosorbent assay (ELISA).

Findings

• Immunocytochemical labelling was able to pick up R. equi in smears from about 73.2% of the symptomatic foals and 70.4% of the control group.
• Through ELISA testing, it was determined that 36 of the control foals (66.7%) and 37 of the affected foals (66.1%) were seropositive for R.equi.
• There was no meaningful difference between the results of the affected and the control foals (P>0.05), suggesting that the ranking of ICC and ELISA as diagnostic tools might be on par.
• Significantly, the research also showed that there was no notable difference in results whether using ICC or ELISA (P>0.05).
• Consequently, ICC may be just as useful as a diagnostic tool.
• The team also found that the presence of clinical signs of illness was not clearly correlated with the results of the ELISA or ICC tests.

Implications

• The research established the potential of an immunocytochemical procedure in identifying R. equi in smears of tracheal samples from foals.
• If the accuracy of ICC proves to be comparable to the established ELISA method, it could offer an alternative testing strategy for identifying Rhodococcus equi.
• Due to the absence of a strong connection between clinical signs and the results of either the ELISA or ICC tests, additional research may be needed to refine these methods or develop better predictive screening models.